The nurse is providing instruction about ipratropium (Atrovent) to a patient with COPD. Which is a common adverse effect that tends to resolve with therapy?
Dry mouth
Anxiety
Tachycardia
Urine retention
The Correct Answer is A
A. Dry mouth
Dry mouth is a common adverse effect of ipratropium (Atrovent) due to its anticholinergic properties. Anticholinergic medications can inhibit saliva production, leading to a sensation of dryness in the mouth. While uncomfortable, dry mouth tends to improve over time as the body adjusts to the medication. Patients can manage dry mouth by increasing fluid intake and practicing good oral hygiene.
B. Anxiety
Anxiety is not a common adverse effect of ipratropium (Atrovent). While some individuals may experience anxiety as a side effect of certain medications, it is not typically associated with ipratropium. If a patient experiences anxiety while taking ipratropium, it is essential to assess whether it may be related to other factors or medications and to consult a healthcare provider for appropriate management.
C. Tachycardia
Tachycardia (rapid heart rate) is not a common adverse effect of ipratropium (Atrovent). While ipratropium is an anticholinergic medication that can affect heart rate in some individuals, tachycardia is not typically reported as a common side effect. However, patients should be monitored for changes in heart rate and other cardiovascular effects while taking ipratropium, especially if they have pre-existing cardiac conditions.
D. Urine retention
Urinary retention is a potential adverse effect of ipratropium (Atrovent) due to its anticholinergic properties. Anticholinergic medications can relax the smooth muscle of the bladder, leading to difficulty emptying the bladder completely. However, urinary retention is less common with ipratropium compared to other anticholinergic medications, such as those used to treat overactive bladder. Patients experiencing urinary retention while taking ipratropium should consult their healthcare provider for further evaluation and management.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
A. Facial flushing
Facial flushing is not typically associated with atelectasis. Instead, it may occur in conditions such as oxygen toxicity or fever.
B. Increasing dyspnea
Atelectasis is a condition characterized by the collapse or partial collapse of a portion of the lung. Common findings in a client with atelectasis include increasing dyspnea (shortness of breath) due to impaired gas exchange and reduced lung function. As the affected lung tissue collapses, ventilation and oxygenation are compromised, leading to difficulty breathing.
C. Decreasing respiratory rate
A decreasing respiratory rate is not typically observed in a client with atelectasis. Instead, respiratory rate may increase as the body attempts to compensate for the impaired gas exchange and oxygenation resulting from lung collapse.
D. Dry cough
While coughing is a common symptom of atelectasis, it is typically associated with a productive cough rather than a dry cough. A dry cough is more commonly associated with conditions such as viral respiratory infections or allergic reactions. In atelectasis, the cough may be productive as the body attempts to clear mucus or other secretions from the affected airways.
Correct Answer is A
Explanation
A. Liver function tests
This is the correct choice. Pyrazinamide, a medication used in the treatment of tuberculosis, is known to potentially cause hepatotoxicity, which refers to liver damage or dysfunction. Therefore, clients prescribed pyrazinamide should undergo regular monitoring of liver function tests to assess for any signs of liver injury or impairment. Liver function tests typically include measurements of various enzymes and proteins produced by the liver, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and bilirubin levels.
B. Gallbladder studies
Gallbladder studies are not typically indicated for clients taking pyrazinamide. While pyrazinamide can rarely cause hepatotoxicity, which may affect liver function, it is not known to specifically target or affect the gallbladder. Therefore, routine gallbladder studies are not necessary for clients taking pyrazinamide.
C. Thyroid function studies
Pyrazinamide is not known to directly affect thyroid function. Therefore, routine thyroid function studies are not indicated for clients taking pyrazinamide unless there are specific signs or symptoms suggesting thyroid dysfunction.
D. Blood glucose levels
Pyrazinamide is not known to directly affect blood glucose levels. Therefore, routine monitoring of blood glucose levels is not indicated for clients taking pyrazinamide unless there are specific reasons to suspect or monitor for diabetes mellitus or other conditions affecting blood glucose regulation.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today